Can I read Multiple drugs: Classical Hodgkin lymphoma, drug toxicity in the form of interstitial lung disease and lack of efficacy : case report on EtoBox?

Multiple drugs: Classical Hodgkin lymphoma, drug toxicity in the form of interstitial lung disease and lack of efficacy : case report is a Medicine article available to read on EtoBox.

What is Multiple drugs: Classical Hodgkin lymphoma, drug toxicity in the form of interstitial lung disease and lack of efficacy : case report about?

Multiple drugs Classical Hodgkin lymphoma, drug toxicity in the form of interstitial lung disease and lack of efficacy : case report A 63-old-year-old man developed classical Hodgkin lymphoma during treatment with bortezomib, thalidomide and dexamethasone for multiple myeloma and melphalan for conditioning chemotherapy for autologous stem cell transplant. Additionally, he developed drug toxicity in the form of interstitial lung disease during treatment with bleomycin for classical Hodgkin lymphoma. Also, he exhibited lack of efficacy during treatment with doxorubicin, bleomycin, vinblastine and dacarbazine for classical Hodgkin lymphoma [not all routes, dosages and outcomes stated; durations of treatments to reaction onsets not stated]. The man with insulin-controlled diabetes from the past 4 years was diagnosed with multiple myeloma. He started receiving cyclical treatment with bortezomib, thalidomide and dexamethasone for 3 cycles. He underwent autologous stem cell transplant. He received conditioning regimen with melphalan 200 mg/m 2 on the day 1 after the transplant. He also received prophylactic moxifloxacin antibiotic therapy, fluconazole antifungal therapy and aciclovir anti

Who reads Multiple drugs: Classical Hodgkin lymphoma, drug toxicity in the form of interstitial lung disease and lack of efficacy : case report?

Publisher

Springer Science and Business Media LLC

Published

2023

Language

EN

Field

Medicine (Health Sciences)